Abstract
Globally, a high prevalence of multi-drug-resistant (MDR) bacteria, mostly methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae, has been reported. Infections caused by such bacteria are expensive and hard to treat due to reduced efficient treatment alternatives. Centered on the current rate of antibiotics production and approvals, it is anticipated that by 2050 up to 10 million people could die annually due to MDR pathogens. To this effect, alternative strategies such as the use of nanotechnology to formulate nanobactericidal agents are being explored. This systematic review addresses the recent approaches, future prospects, and challenges of nanotechnological solutions for controlling transmission and emergence of antibiotic resistance. A comprehensive literature search of PubMed and BioMed Central databases from June 2018 to January 2019 was performed. The search keywords used were “use of nanotechnology to control antibiotic resistance” to extract articles published only in English encompassing all research papers regardless of the year of publication. PubMed and BioMed Central databases literature exploration generated 166 articles of which 49 full-text research articles met the inclusion guidelines. Of the included articles, 44.9%, 30.6%, and 24.5% reported the use of inorganic, hybrid, and organic nanoparticles, respectively, as bactericidal agents or carriers/enhancers of bactericidal agents. Owing to the ever-increasing prevalence of antimicrobial resistance to old and newly synthesized drugs, alternative approaches such as nanotechnology are highly commendable. This is supported by in vitro, ex vivo, and in vivo studies assessed in this review as they reported high bactericide efficacies of organic, inorganic, and hybrid nanoparticles.
Similar content being viewed by others
Abbreviations
- MDR:
-
Multidrug resistant
- MRSA:
-
Methicillin-resistant Staphylococcus aureus
- MSSA:
-
Methicillin-sensitive Staphylococcus aureus
- CRE:
-
Carbapenem-resistant Enterobacteriaceae
- AMR:
-
Antimicrobial resistance
- IS:
-
Insertion sequence
- NP:
-
Nanoparticles
- MIC:
-
Minimum inhibitory concentration
- MBC:
-
Minimum bactericidal concentration
- PDR:
-
Pan drug resistant
- ANOVA:
-
Analysis of variance
- μg:
-
Microgram
- ml:
-
Milliliter
- TPU:
-
Thermoplastic polyurethane
- DA:
-
Polydopamine
- NS:
-
Nanosilver
- pSWCNT-Ag:
-
Pegylated silver-coated single-walled carbon nanotubes
- SWCNT-Ag:
-
Silver-coated single-walled carbon nanotubes
- PHEMA:
-
Polyhydroxyethyl methacrylate
- BMP-2:
-
Bone morphogenetic protein 2
- PLGA:
-
Poly-DL-lactic-co-glycolic acid
- PAH:
-
Polyelectrolyte
- MNP-CSA-13:
-
Ceragenin-coated iron oxide magnetic NPs
- CSA-13:
-
Ceragenin 13
- ZNG:
-
Zinc oxide nanorods-graphene nanoplatelets
- DMAP-PTA:
-
Dimethyl amino pyridine propylthioacetate
- CdTe:
-
Cadmium tellurium
- TiO2 :
-
Titanium oxide
- MPA:
-
Mercaptopropionic acid
- QD:
-
Quantum dots
- SLN:
-
Solid lipid nanoparticles
- EO:
-
Essential oil
- Cipro:
-
Ciprofloxacin
- CSNP:
-
Chitosan nanoparticles
- mPEG:
-
Monomethoxy polyethylene glycol
- OA:
-
Oleic acid
- PCL:
-
Poly Ɛ-caprolactone
- GO:
-
Graphene oxide
- SMZ:
-
Sulfamethoxazole
- MCP-1:
-
Monocyte chemoattractant protein-1
- IL:
-
Interleukin
- BA:
-
Bacitracin A
- ZIF:
-
Zeolitic imidazolate framework
- TEM:
-
Transmission electron microscopy
- SEM:
-
Scanning electron microscopy
- FETEM:
-
Field emission transmission electron microscopy
- HRTEM:
-
High-resolution transmission electron microscopy
- DLS:
-
Dynamic light scattering
- ATR-FTIR:
-
Attenuated total reflectance Fourier transform-infrared spectroscopy
- FTIR:
-
Fourier transform-infrared spectroscopy
- AFM:
-
Atomic force microscopy
- XRD:
-
X-ray diffraction
- EDX:
-
Energy dispersive X-ray spectroscopy
- DSC:
-
Differential scanning calorimeter
- TGA:
-
Thermogravimetric analysis
- DRS:
-
UV-visible diffuse reflectance spectroscopy
- XPS:
-
X-ray photoelectron spectroscopy
- SOD:
-
Superoxide dismutase
- Mtb:
-
Mycobacterium tuberculosis
- ROS:
-
Reactive oxygen species
- MTT:
-
(Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- XTT:
-
2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT)
- CCK:
-
Cell Counting Kit-8
- UV:
-
Ultraviolet
References
Addae et al (2014) Investigation of antimicrobial activity of photothermal therapeutic gold/copper sulfide core/shell nanoparticles to bacterial spores and cells. J Biol Eng 8:11. https://doi.org/10.1186/1754-1611-8-11
Ali SW, Joshi M, Rajendran S (2011) Synthesis and characterization of chitosan nanoparticles with enhanced antimicrobial activity. Int J Nanosci 10(4 & 5):979–984. https://doi.org/10.1142/S0219581X1100868X
Alves TF, Chaud MV, Grotto D, Jozala AF, Pandit R, Rai M, dos Santos CA (2017) Association of silver Nanoparticles and curcumin solid dispersion: antimicrobial and antioxidant properties. AAPS PharmSciTech 19(1):225–231. https://doi.org/10.1208/s12249-017-0832-z
Ansari MA, Khan HM, Khan AA, Cameotra SS, Saquib Q, Musarrat J (2014) Interaction of Al2O3 nanoparticles withEscherichia coli and their cell envelope biomolecules. J Appl Microbiol 116(4):772–783. https://doi.org/10.1111/jam.12423
Anwar A, Khalid S, Perveen S, Ahmed S, Siddiqui R, Khan NA, Shah MR (2018) Synthesis of 4-(dimethylamino) pyridine propylthioacetate coated gold nanoparticles and their antibacterial and photophysical activity. Nanobiotechnol 16:6. https://doi.org/10.1186/s12951-017-0332-z
Asadishad B, Hidalgo G, Tufenkji N (2012) Pomegranate materials inhibit flagellin gene expression and flagellar-propelled motility of uropathogenic Escherichia coli strain CFT073. FEMS Microbiol Lett 334:87–94
Asgarali A, Stubbs KA, Oliver A, Vocadlo DJ, Mark BL (2009) Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53:2274–2282
Bansod SD, Bawaskar MS, Gade AK, Rai MK (2015) Development of shampoo, soap and ointment formulated by green synthesised silver nanoparticles functionalised with antimicrobial plants oils in veterinary dermatology: treatment and prevention strategies. IET Nanobiotechnol 9(4):165–171. https://doi.org/10.1049/iet-nbt.2014.0042
Billal DS, Feng J, Leprohon P, Legare D, Ouellette M (2011) Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. BMC Genomics 12:512
Brody T, Yavatkar AS, Lin Y, Ross J, Kuzin A et al (2008) Horizontal gene transfers link a human MRSA pathogen to contagious bovine mastitis bacteria. PLoS One 3(8):e3074. https://doi.org/10.1371/journal.pone.0003074
Burygin G, Khlebtsov B, Shantrokha A, Dykman L, Bogatyrev V, Khlebtsov N et al (2009) On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res Lett 4:794–801. https://doi.org/10.1007/s11671-009-9316-8
Castro L, Blázquez ML, González FG, Ballester A (2014) Mechanism and applications of metal nanoparticles prepared by bio-mediated process. Rev Adv Sci Eng 3:199–216
CDC (2013) Antibiotic resistance threats in the United States
Centre for Disease Dynamics, Economics and Policy (CDDEP) (2015) The state of the world’s antibiotics. Washington DC-New Delhi
Ceri H, Olson ME, Stremick C (1999) The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771–1776
Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE (2016) Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Nat Sci Rep 6:26717. https://doi.org/10.1038/srep26717
Chatterjee et al (2011) Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application. J Nanobiotechnol 9:34. https://doi.org/10.1186/1477-3155-9-34
Chemello G, Piccinetti C, Randazzo B, Carnevali O, Maradonna F, Magro M, Olivotto I (2016) Oxytetracycline delivery in adult female zebrafish by iron oxide nanoparticles. Zebrafish 13(6):495–503. https://doi.org/10.1089/zeb.2016.1302
Cheng et al (2009) The effects of the bacterial interaction with visible-light responsive titania photocatalyst on the bactericidal performance. J Biomed Sci 16:7. https://doi.org/10.1186/1423-0127-16-7
Choi SJ, Oh JM, Choy JH (2010) Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study. J Nanosci Nanotechnol 10:2913–2916
Choksakulnimitr S, Masuda S, Tokuda H, Takakura Y, Hashida M (1995) In vitro cytotoxicity of macromolecules in different cell culture systems. J Control Release 34:233–241
Colonna C, Conti B, Perugini P, Pavanetto F, Modena T (2007) Chitosan glutamate nanoparticles for protein delivery: development and effect on prolidase stability. J Microencapsul 24:553–564
Cui L, Chen P, Chen S, Yuan Z, Yu C, Ren B, Zhang K (2013) In situ study of the antibacterial activity and mechanism of action of silver nanoparticles by surface-enhanced Raman spectroscopy. Anal Chem 85:5436–5443
Da Silva Gündel S, de Souza ME, Quatrin PM, Klein B, Wagner R, Gündel A, Ourique AF (2018) Nanoemulsions containing Cymbopogon flexuosus essential oil: development, characterization, stability study and evaluation of antimicrobial and antibiofilm activities. Microb Pathog 118:268–276. https://doi.org/10.1016/j.micpath.2018.03.043
de la Fuente JM, Grazu V (2012) Nanobiotechnology, inorganic nanoparticles vs organic nanoparticles. Frontiers of nanoscience, vol 4. Elsevier Ltd
Devalapally H, Chakilam A, Amiji MM (2007) Role of nanotechnology in pharmaceutical product development. J Pharm Sci 96:2547–2565. https://doi.org/10.1002/jps
Economou V, Gousia P (2015) Agriculture and food animals as a source of antimicrobial-resistant bacteria. NCBI, Dove Medicine Press. Infect Drug Resist 8:49–61
Ercan B, Taylor E, Alpaslan E, Webster TJ (2011) Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology 22(29):295102. https://doi.org/10.1088/0957-4484/22/29/295102
Fazly Bazzaz BS, Khameneh B, Namazi N, Iranshahi M, Davoodi D, Golmohammadzadeh S (2018) Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity. Lett Appl Microbiol 66(6):506–513. https://doi.org/10.1111/lam.12886
Gao W et al (2010) Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 6:e1000944
Gao W, Chen Y, Chang Y, Zhang Y, Chang Q, Zhang L (2018) Nanoparticle-based local antimicrobial drug delivery. Adv Drug Deliv Rev 127:46–57. https://doi.org/10.1016/j.addr.2017.09.015
Gholap H, Patil R, Yadav P, Banpurkar A, Ogale S, Gade W (2013) CdTe–TiO2nanocomposite: an impeder of bacterial growth and biofilm. Nanotechnology 24(19):195101. https://doi.org/10.1088/0957-4484/24/19/195101
Graves JL, Tajkarimi M, Cunningham Q, Campbell A, Nonga H, Harrison SH, Barrick JE (2015) Rapid evolution of silver nanoparticle resistance in Escherichia coli. Front Genet 6:42. https://doi.org/10.3389/fgene.2015.00042
Gulmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, Kocagoz S, Uzun O, Hascelik G.& Livermore DM. (2008) Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 31:523–526
Guzmán MG, Dille J, Godet S (2009) Synthesis of silver nanoparticles by chemical reduction method and their antibacterial activity. Int J Chem Biomol Eng 2:104–111
Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P (2004) Comparison of alamar blue and MTT assays for high through-put screening. Toxicol in Vitro 18:703–710
Hausner M, Wuertz S (1999) High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol 65(8):3710–3713
He et al (2016) Study on the mechanism of antibacterial action of magnesium oxide nanoparticles against foodborne pathogens. Nanobiotechnol 14:54. https://doi.org/10.1186/s12951-016-0202-0
Hinchliffe P, Symmons MF, Hughes C, Koronakis V (2013) Structure and operation of bacterial tripartite pumps. Annu Rev Microbiol 67:221–242
Hofmann D, Messerschmidt C, Bannwarth MB, Landfester K, Mailander V (2014) Drug delivery without nanoparticle uptake: delivery by a kiss-andrun mechanism on the cell membrane. Chem Commun (Camb) 50:1369–1371
Høiby N, Bjarnsholt T, Givskov M (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322–332
Hong W, Liu L, Zhao Y, Liu Y, Zhang D, Liu M (2018) Pluronic-based nano-self-assemblies of bacitracin a with a new mechanism of action for an efcient in vivo therapeutic effect against bacterial peritonitis. J Nanobiotechnol 16:66. https://doi.org/10.1186/s12951-018-0397-3
Hou Y, Hu J, Park H, Lee M (2012) Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications. J Biomed Mater Res A 100:939–947
Huang L, Weng X, Chen Z, Megharaj M, Naidu R (2014) Green synthesis of iron nanoparticles by various tea extracts: comparative study of the reactivity. Spectrochim Acta A Mol Biomol Spectrosc 130:295–301
Islam et al (2017) A multi-target therapeutic potential of Prunus domestica gum stabilized nanoparticles exhibited prospective anticancer, antibacterial, urease-inhibition, anti-inflammatory and analgesic properties. BMC Complement Altern Med 17:276. https://doi.org/10.1186/s12906-017-1791-3
Ivask A, El Badawy A, Kaweeteerawat C, Boren D, Fischer H, Ji Z et al (2014) Toxicity mechanisms in Escherichia coli vary for silver nanoparticles and differ from ionic silver. ACS Nano 8:374–386
Iyamba J-ML, Wambale JM, Lukukula CM, Takaisi-Kikuni NB (2014) High prevalence of methicillin resistant staphylococci strains isolated from surgical site infections in Kinshasa. Pan Afr Med J 18:322. https://doi.org/10.11604/pamj.2014.18.322.4440
Jafari A, Jafari Nodooshan S, Safarkar R, Movahedzadeh F, Mosavari N, Novin Kashani A, Majidpour A (2017) Toxicity effects of AgZnO nanoparticles and rifampicin on mycobacterium tuberculosis into the macrophage. J Basic Microbiol 58(1):41–51. https://doi.org/10.1002/jobm.201700289
Jahnke JP, Cornejo JA, Sumner JJ, Schuler AJ, Atanassov P, Ista LK (2016) Conjugated gold nanoparticles as a tool for probing the bacterial cell envelope: the case of Shewanella oneidensis MR-1. Biointerphases. 11:11003
Kawata K, Osawa M, OkabeS (2009) In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046–6051
Khan M, Khan M, Adil SF, Tahir MN, Tremel W, Alkhathlan HZ, Al-Warthan A, Siddiqui MRH (2013) Green synthesis of silver nanoparticles mediated by Pulicaria glutinosa extract. Int J Nanomedicine 8:1507–1516
Khan ST, Ahmad J, Ahamed M, Musarrat J, Al-Khedhairy AA (2016) Zinc oxide and titanium dioxide nanoparticles induce oxidative stress, inhibit growth, and attenuate biofilm formation activity of Streptococcus mitis. J Biol Inorg Chem 21(3):295–303. https://doi.org/10.1007/s00775-016-1339-x
Khan I, Saeed K, Khan I (2017) Nanoparticles: Properties, applications and toxicities. Arab J Chem 12:908–931. https://doi.org/10.1016/j.arabjc.2017.05.011
Kierys A (2014) Synthesis of aspirin-loaded polymer-silica composites and their release characteristics. ACS Appl Mater Interfaces 6(16):14369–14376
Kose N, Otuzbir A, Peksen C, Kiremitc A, Dogan A (2013) A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance. Clin Orthop Relat Res 471:2532–2539. https://doi.org/10.1007/s11999-013-2894-x
Kvitek A, Panacek J, Soukupova M, Kolar R, Vecerova R, Prucek M, Holecova R (2008) ZborilEffect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs) J. Phys Chem C 112:5825–5834
Lai XZ, Feng Y, Pollard J, Chin JN, Rybak MJ, Bucki R, Epand RF, Epand RM, Savage PB (2008) Ceragenins: cholic acidbased mimics of antimicrobial peptides. Acc Chem Res 41(10):1233–1240
Lai H-Z, Chen W-Y, Wu C-Y, Chen Y-C (2015) Potent antibacterial nanoparticles for pathogenic bacteria. ACS Appl Mater Interfaces 7:2046–2054
Lavigne JP, Sotto A, Nicolas-Chanoine MH, Bouziges N, Pagès JM, Davin-Regli A (2013) An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates. Int J Antimicrob Agents 41:130–136
Levison ME, Levison JH (2009 December) Pharmacokinetics and pharmacodynamics of antibacterial agents. Infect Dis Clin N Am 23(4):791–vii. https://doi.org/10.1016/j.idc.2009.06.008
Li B, Jiang B, Boyce BM, Lindsey BA (2009) Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections. Biomaterials 30(13):2552–2558. https://doi.org/10.1016/j.biomaterials.2009.01.042
Li B, Jiang B, Dietz MJ, Smith ES, Clovis NB, Rao KMK (2010) Evaluation of local MCP-1 and IL-12 nanocoatings for infectionprevention in open fractures. J Orthop Res 28(1). https://doi.org/10.1002/jor.20939
Li M, Zhu L, Lin D (2011) Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ Sci Technol 45:1977–1983
Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM (2012) Structure and function of OprD protein in PseudoImonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol 302:63–68
Liu et al (2018) Nano-silver-incorporated biomimetic polydopamine coating on a thermoplastic polyurethane porous nanocomposite as an efficient antibacterial wound dressing. J Nanobiotechnol 16:89. https://doi.org/10.1186/s12951-018-0416-4
Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N (2011) What remains against carbapenem resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofoxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 37:415–424
Long KS, Poehlsgaard J, Kehrenberg C, Schwarz S, Vester B (2006) The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 50:2500–2505
Loomba PS, Taneja J, Mishra B (2010) Methicillin and vancomycin resistant S. aureus in hospitalized patients. J Global Infect Dis 2(3):275–283. https://doi.org/10.4103/0974-777X.68535
Louie A, VanScoy BD et al (2012) Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamics model. Antimicrob Agents Chemother 56:1229–1239
Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265–1273. https://doi.org/10.1172/JCI200318535
Lu Z, Rong K, Li J, Yang H, Chen R (2013) Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria. J Mater Sci Mater Med 24:1465–1471
Luo Y, Hossain M, Wang C, Qiao Y, An J, Ma L, Su M (2013) Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. Nanoscale 5(2):687–694. https://doi.org/10.1039/c2nr33154c
Marei N, Elwahy AHM, Salah TA, El-Sherif Y, El-Samie EA (2018) Enhanced antibacterial activity of Egyptian local insects’ chitosanbased nanoparticles loaded with ciprofloxacin-HCl. Int J Biol Macromol 126:262–272. https://doi.org/10.1016/j.ijbiomac.2018.12.204
Markova Z, Šiškova K, Filip J et al (2012) Chitosan-based synthesis of magnetically-driven nanocomposites with biogenic magnetite core, controlled silver size, and high antimicrobial activity. Green Chem 14:2550–2558. https://doi.org/10.1039/C2GC35545K
Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17(2):1247–1248
McKenzie C (2011) Antibiotic dosing in critical illness. J Antimicrob Chemother 66(Suppl 2):ii25–ii31. https://doi.org/10.1093/jac/dkq516
McQuillan JS, Shaw AM (2014) Differential gene regulation in the Ag nanoparticle and Ag+-induced silver stress response in Escherichia coli: a full transcriptomic profile. Nanotoxicology. 8:177–184
Meghana S, Kabra P, Chakraborty S, Padmavathy N (2015) Understanding the pathway of antibacterial activity of copper oxide nanoparticles. RSC Adv 5:12293–12299
Michalikova L, Hnilicova S. and Brnova J (2017) Nanoshield surface coating protection combination with cleaning product cleaner for removal bacterial contamination. Abstracts from the 4th International Conference on Prevention & Infection Control (ICPIC 2017). Geneva, Switzerland. 20–23 June 2017 Antimicrobial Resistance and Infection Control, 6(Suppl 3):P390. https://doi.org/10.1186/s13756-017-0201-4
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Muller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47:3–19
Nair LS, Laurencin CT (2008) Nanofibers and nanoparticles for orthopaedic surgery applications. J Bone Jt Surg Am 90:128–131
Naz et al (2013) Enhanced biocidal activity of Au nanoparticles synthesized in one pot using 2, 4-dihydroxybenzene carbodithioic acid as a reducing and stabilizing agent. J Nanobiotechnol 11:13. https://doi.org/10.1186/1477-3155-11-13
Neu HC (1992) The crisis in antibiotic resistance. Science 257:1064–1073
Niemirowicz et al (2015) Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles. J Nanobiotechnol 13:32. https://doi.org/10.1186/s12951-015-0093-5
Nordmann P, Poirel L, Walsh TR, Livermore DM (2011) The emerging NDM carbapenemases. Trends Microbiol 19:588–595
Nordmann P, Dortet L, Poirel L (2012) Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 18(5):263–272
Novais  et al (2012) Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones. Eur J Clin Microbiol Infect Dis 31:3057–3063
Omolo CA, Kalhapure RS, Jadhav M, Rambharose S, Mocktar C, Ndesendo VMK, Govender T (2017) Pegylated oleic acid: a promising amphiphilic polymer for nano-antibiotic delivery. Eur J Pharm Biopharm 112:96–108. https://doi.org/10.1016/j.ejpb.2016.11.022
Padmavathy N, Vijayaraghavan R (2008) Enhanced bioactivity of ZnO nanoparticles an antimicrobial study. Sci Technol Adv Mater 9:35004
Palanisamy et al (2014) Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa. J Nanobiotechnol 12:2. https://doi.org/10.1186/1477-3155-12-2
Panáček A, Smékalová M, Kilianová M, Prucek R, Bogdanová K, Večeřová R, Kolář M, Havrdová M, Płaza GA, Chojniak J, Zbořil R, Kvítek L (2015) Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect. Molecules. 21(1):E26
Panáček A, Kvítek L, Smékalová M, Večeřová R, Kolář M, Röderová M, Dyčka F, Šebela M, Prucek R, Tomanec O, Zbořil R (2017) Bacterial resistance to silver nanoparticles and how to overcome it. Nat Nanotechnol 13(1):65–71. https://doi.org/10.1038/s41565-017-0013-y
Park et al (2018) Proteomic analysis of antimicrobial effects of pegylated silver coated carbon nanotubes in Salmonella enterica serovar Typhimurium. J Nanobiotechnol 16:31. https://doi.org/10.1186/s12951-018-0355-0
Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother 51:3471–3484
Pérez-Díaz MA, Boegli L, James G, Velasquillo C, Sánchez-Sánchez R, Martínez-Martínez R-E, Martínez-Castañón GA, Martinez-Gutierrez F (2015) Silver nanoparticles with antimicrobial activities against Streptococcus mutans and their cytotoxic effect. Mater Sci Eng C 55:360–366
Pfeifer Y, Schlatterer K, Engelmann E, Schiller RA, Frangenberg HR, Stiewe D et al (2012) Emergence of OXA-48 type carbapenemase producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother 56:2125–2128
Pini A, Giuliani A, Falciani C et al (2005) Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother 49(7):2665–2672
Poirel L, Nordmann P (2006) Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50:1442–1448
Power E, Schering–Plough Corporation, Global Medical Affairs, Kenilworth, NJ, USA (2006) Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect 12(Suppl. 5):25–34
Punina NV, Makridakis NM, Remnev MA, Topunov AF (2015) Whole-genome sequencing targets drug-resistant bacterial infections. Hum Genomics 9:19. https://doi.org/10.1186/s40246-015-0037-z
Queenan AM, Bush K (2007) Carbapenemases: the versatile lactamases. Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, New Jersey 08869 American Society for Microbiology 20(23):440–458
Rafińska K, Pomastowski P, Buszewski B (2019) Study of Bacillus subtilis response to different forms of silver. Sci Total Environ 661:120–129. https://doi.org/10.1016/j.scitotenv.2018.12.139
Ramalingam B, Parandhaman T, Das SK (2016) Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of gram-negative bacteria viz. Escherichia coli and Pseudomonas aeruginosa. ACS Appl Mater Interfaces 8:4963–4976
Raman G, Park SJ, Sakthivel N, Suresh AK (2017) Physico-cultural parameters during AgNPs biotransformation with bactericidal activity against human pathogens. Enzym Microb Technol 100:45–51. https://doi.org/10.1016/j.enzmictec.2017.02.002
Reithofer MR, Lakshmanan A, Ping ATK, Chin JM, Hauser CAE (2014) In situ synthesis of size-controlled, stable silver nanoparticles within ultrashort peptide hydrogels and their anti-bacterial properties. Biomaterials 35(26):7535–7542. https://doi.org/10.1016/j.biomaterials.2014.04.102
Ren G, Hu D, Cheng EWC, Vargas-Reus MA, Reip P, Allaker RP (2009) Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents 33:587–590
Rizzello L, Pompa PP (2014) Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines. Chem Soc Rev 43(5):1501–1518. https://doi.org/10.1039/c3cs60218d
Ruggerone P, Murakami S, Pos KM, Vargiu AV (2013) RND efflux pumps: structural information translated into function and inhibition mechanisms. Curr Top Med Chem 13:3079–3100
Sadurní N, Solans C, Azemar N, García-Celma MJ (2005) Studies on the formation of O / W nano-emulsions, by low-energy emulsification methods, suitable for pharmaceutical applications. Eur J Pharm Sci 26:438–445. https://doi.org/10.1016/j.ejps.2005.08.001
Salehi et al (2014) Investigation of antibacterial effect of cadmium oxide nanoparticles on Staphylococcus aureus bacteria. J Nanobiotechnol 12:26. https://doi.org/10.1186/s12951-014-0026-8
Saude A, Ombredani A, Silva O, Barbosa J, Moreno S, Dias S, Franco OL (2014) Clavanin bacterial sepsis control using a novel methacrylate nanocarrier. Int J Nanomed 5055. https://doi.org/10.2147/ijn.s66300
Seil JT, Webster TJ (2012) Antibacterial effect of zinc oxide nanoparticles combined with ultrasound. Nanotechnology 23(49):495101. https://doi.org/10.1088/0957-4484/23/49/495101
Selvaraj RCA, Rajendran M, Nagaiah HP (2019) Re-potentiation ofβ-lactam antibiotic by synergistic combination with biogenic copper oxide nanocubes against biofilm forming multidrug-resistant bacteria. Molecules 2019(24):3055. https://doi.org/10.3390/molecules24173055
Senarathna ULNH, Fernando SSN, Gunasekara TDCP, Weerasekera MM, Hewageegana HGSP, Arachchi NDH, Siriwardena HD, Jayaweera PM (2017) Enhanced antibacterial activity of TiO2 nanoparticle surface modified with Garcinia zeylanica extract. Chem Cent J 11:7. https://doi.org/10.1186/s13065-017-0236-x
Shaaban MI, Shaker MA, Mady FM (2017) Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates. J Nanobiotechnol 15:29. https://doi.org/10.1186/s12951-017-0262-9
Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 3:168–171
Silver S, Phoung LT (2005) A bacterial view of the periodic table: genes and proteins for toxic inorganic ions. J Ind Microbiol Biotechnol 2005(32):587–605
Simon-Deckers A, Loo S, Mayne-L’hermite M, Herlin-Boime N, Menguy N, Reynaud C et al (2009) Size-, composition- and shape-dependent toxicological of metal oxide nanoparticles and carbon nanotubes toward bacteria. Environ Sci Technol 43:8423–8429
Singh et al (2014) Green silver nanoparticles of Phyllanthus amarus: as an antibacterial agent against multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Nanobiotechnol 12:40. https://doi.org/10.1186/s12951-014-0040-x
Slavin YN, Asnis J, Häfeli UO, Bach H (2017) Metal nanoparticles: understanding the mechanisms behind antibacterial activity. J Nanobiotechnol 15:65. https://doi.org/10.1186/s12951-017-0308-z
Sowmya C, Lavakumar V, Venkateshan N, Ravichandiran V, Saigopal DVR (2018) Exploration of Phyllanthus acidus mediated silver nanoparticles and its activity against infectious bacterial pathogen. Chem Cent J 12:42. https://doi.org/10.1186/s13065-018-0412-7
Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr (2004) Trends in antimicrobial drug development: implications for the future. Infect Dis Ther 38:1279–1286
Spratt BG (1994) Resistance to antibiotics mediated by target alterations. Science 264:388–393
Ssekatawa K, Byarugaba DK, Wampande E, Ejobi F (2018) A systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes 11:1–9. https://doi.org/10.1186/s13104-018-3738-2
Stapleton PD, Taylor PW (2002) Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Europe PMC Funders Group Author Manuscript. 85:57–72
Su H-L, Lin S-H, Wei J-C, Pao I-C, Chiao S-H et al (2011) Novel nanohybrids of silver particles on clay platelets for inhibiting silver-resistant bacteria. PLoS One 6(6):e21125. https://doi.org/10.1371/journal.pone.0021125
Tahir MN, Natalio F, Cambaz MA, Panthöfer M, Branscheid R, Kolb U, Tremel W (2013) Controlled synthesis of linear and branched Au@ ZnO hybrid nanocrystals and their photocatalytic properties. Nanoscale 5:9944–9949
Tajkarimi M, Rhinehardt K, Thomas M, Ewunkem AJ, Campbell A, Boyd S, Turner D, Harrison SH, Graves JL (2017) Selection for ionic- confers silver nanoparticle resistance in Escherichia coli. JSM Nanotechnol Nanomed 5:1047
Tangden T, Adler M, Cars O, Sandegren L, Lowdin E (2013) Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model. J Antimicrob Chemother 68:1319–1326
Taylor E, Webster TJ (2011) Reducing infections through nanotechnology and nanoparticles. Int J Nanomedicine 6:1463–1473
Thati V, Shivannavar CT, Gaddad SM (2011) Vancomycin resistance among methicillin resistant Staphylococcus aureusisolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J Med Res 134(5):704–708. https://doi.org/10.4103/0971-5916.91001
Travan A, Pelillo C, Donati I, Marsich E, Benincasa M, Scarpa T, Semeraro S, Turco G, Gennaro R, Paoletti S (2009) Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity. Biomacromolecules. 10:1429–1435
Umashankari et al (2012) Mangrove plant, Rhizophora mucronata (Lamk, 1804) mediated one pot green synthesis of silver nanoparticles and its antibacterial activity against aquatic pathogens. Saline Syst 8:11. https://doi.org/10.1186/2046-9063-8-11
Warnes SL, Highmore CJ, Keevil CW (2012) Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: implications for public health. American Society for Microbiology 3:6–12
Wright GD (2005) Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 57:1451–1470
Wu S, Zuber F, Maniura-Weber K, Brugger J, Ren Q (2018) Nanostructured surface topographies have an effect on bactericidal activity. J Nanobiotechnol 16:20. https://doi.org/10.1186/s12951-018-0347-0
Xu T, Zhang J, Zhu Y, Zhao W, Pan C, Ma H, Zhang L (2018) A poly (hydroxyethyl methacrylate)–Ag nanoparticle porous hydrogel for simultaneous in vivo prevention of the foreign-body reaction and bacterial infection. Nanotechnology 29(39):395101. https://doi.org/10.1088/1361-6528/aad257
Yao C, Webster TJ, Hedrick M (2013) Decreased bacteria density on nanostructured polyurethane. J Biomed Mater Res A 102(6):1823–1828. https://doi.org/10.1002/jbm.a.34856
Yuan Y, Zhang Y (2017) Enhanced biomimic bactericidal surfaces by coating with positively-charged ZIF nano-dagger arrays. Nanomedicine 13(7):2199–2207. https://doi.org/10.1016/j.nano.2017.06.003
Zanni E, Bruni E, Chandraiahgari CR, de Bellis G, Santangelo MG, Leone M, Bregnocchi A, Mancini P, Sarto MS, Uccelletti D (2017) Evaluation of the antibacterial power and biocompatibility of zinc oxide nanorods decorated graphene nanoplatelets: new perspectives for antibiodeteriorative approaches. J Nanobiotechnol 15:57. https://doi.org/10.1186/s12951-017-0291-4
Zhao L, Chu PK, Zhang Y, Wu Z (2009) Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 91(1):470–480
Zhenga Z, Yin W, Zarad JN, Lib W et al (2010) The use of BMP-2 coupled – Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. Biomaterials. 31(35):9293–9300. https://doi.org/10.1016/j.biomaterials.2010.08.041
Zhou Y, Kong Y, Kundu S, Cirillo JD, Liang H (2012) Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guérin. J Nanobiotechnol 10:19 http://www.biomedcentral.com/10/1/19
Zou W, Li X, Lai Z, Zhang X, Hu X, Zhou Q (2016) Graphene oxide inhibits antibiotic uptake and antibiotic resistance gene propagation. ACS Appl Mater Interfaces 8(48):33165–33174. https://doi.org/10.1021/acsami.6b09981
Acknowledgments
We are thankful to MAPRONANO ACE for funding this work.
Availability of data and materials
All relevant data has been submitted with the manuscript and therefore no supplementary data.
Funding
The authors declare that this systematic review was funded by Africa Centre of Excellence in Materials, Product Development and Nanotechnology, MAPRONANOACE Makerere University. This study was also funded in part by the Swedish International Development Cooperation Agency (Sida) and Makerere University under Sida Contribution No: 51180060. The grant is part of the European and Developing Countries Clinical Trials Partnership (EDCTP2) program supported by the European Union.
Author information
Authors and Affiliations
Contributions
This work was carried out in collaboration between all authors. Eddie Wampande (EW), Lubwama Michael (LM), Kirabira John Baptist (KJB), Dennis K Byarugaba (DKB), Robert Tweyongyere (RB), and Francis Ejobi (FB) conceptualized and designed the format for this systematic review. Kenneth Ssekatawa (KS), Charles Kato Drago (CKD), and EW performed the literature search and data analysis. All authors drafted the section of literature review. KS, EW, LM, KJB, and CKD wrote the first draft of the manuscript and managed manuscript revisions. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethics and consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Guest Editors: Mamadou Diallo, Abdessattar Abdelkefi, and Bhekie Mamba
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the topical collection: Nanotechnology Convergence in Africa
Rights and permissions
About this article
Cite this article
Ssekatawa, K., Byarugaba, D.K., Kato, C.D. et al. Nanotechnological solutions for controlling transmission and emergence of antimicrobial-resistant bacteria, future prospects, and challenges: a systematic review. J Nanopart Res 22, 117 (2020). https://doi.org/10.1007/s11051-020-04817-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-020-04817-7